Dup15q 2019
Recent articles
Gene linked to multiple forms of autism may boost risk of death from seizures
Mice with extra copies of UBE3A, a gene linked to autism and related conditions, are susceptible to death from seizures.
Gene linked to multiple forms of autism may boost risk of death from seizures
Mice with extra copies of UBE3A, a gene linked to autism and related conditions, are susceptible to death from seizures.
Ultrasensitive blood test may detect autism mutations in utero
A blood test can accurately detect whether a fetus carries large mutations of the kind linked to autism, according to pilot-study results.
Ultrasensitive blood test may detect autism mutations in utero
A blood test can accurately detect whether a fetus carries large mutations of the kind linked to autism, according to pilot-study results.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.